Related Experiment Video
Updated: Aug 14, 2026

Two-photon Imaging of Intracellular Ca2+ Handling and Nitric Oxide Production in Endothelial and Smooth Muscle Cells of an Isolated Rat Aorta
Published on: June 10, 2015
Insulin increases NADH/NAD+ redox state, which stimulates guanylate cyclase in vascular smooth muscle
Andrew M Kahn1, Julius C Allen, Sui Zhang
1Department of Medicine. The University of Texas Health Science Center, Houston 77225, USA.
Background:
Insulin inhibits contraction and migration of primary confluent, cultured canine vascular smooth muscle cells (VSMCs) with inducible nitric oxide synthase (iNOS) by stimulating cyclic GMP (cGMP) production. The present study was performed to determine how insulin stimulates guanylate cyclase activity in these cells.
Methods:
Primary cultured VSMC were obtained from canine femoral arteries. Lactate and pyruvate levels were measured by enzymatic assays, cGMP production by radioimmunoassay, iNOS activity by conversion of arginine to citrulline, and cell contraction by photomicroscopy.
Results:
Insulin (1 nmol/L) increased cGMP production fivefold in VSMC with iNOS while raising the lactate-to-pyruvate ratio (LPR) from 3.1 +/- 0.5 to 10.0 +/- 1.6 (P < .05), indicating a rise in the ratio of reduced/oxidized nicotinamide adenine dinucleotide (NADH/NAD+) redox state of the cell. Insulin's stimulation of cGMP production was blocked by 0.1 mmol/L NG-monomethyl-L-arginine (L-NMMA) indicating dependence on iNOS activity, but insulin did not affect iNOS activity. Blocking insulin's increase in LPR by pyruvate (0.5 mmol/L) or oxaloacetate (0.5 mmol/L) completely inhibited the insulin-stimulated component of cGMP production. Pyruvate also blocked insulin's inhibition of serotonin-induced contraction in nonproliferated cells. In the absence of insulin, 5 mmol/L lactate or isocitrate increased the LPR by 420% +/- 47% and 167% +/- 20%, respectively (both P < .05), and stimulated cGMP production by 1,045% +/- 272% and 278% +/- 33%, respectively (both P < .05) by an L-NMMA-inhibitable mechanism. Although cGMP production in cells with iNOS was increased by insulin, the stimulation of cGMP production in cells without iNOS by 3-(5'-hydroxymethyl-2'furyl)-1-benzyl indazole (YC-1) was not affected by insulin, suggesting that insulin does not stimulate guanylate cyclase activity directly.
Conclusion:
We conclude that insulin increases cGMP production in VSMC with iNOS by raising the cell NADH/NAD+ redox state, which may increase the availability of iNOS-derived NO.
Insights
Insulin boosts cyclic GMP (cGMP) in vascular smooth muscle cells (VSMCs) by altering cellular redox state, not by directly activating guanylate cyclase. This pathway may enhance nitric oxide availability.
Area of Science:
- Biochemistry
- Cellular Biology
- Vascular Physiology
Background:
- Insulin inhibits vascular smooth muscle cell (VSMC) contraction and migration.
- This inhibition is mediated by increased cyclic guanosine monophosphate (cGMP) production in VSMCs expressing inducible nitric oxide synthase (iNOS).
- The precise mechanism by which insulin stimulates guanylate cyclase activity remained unclear.
Purpose of the Study:
- To elucidate the mechanism by which insulin stimulates guanylate cyclase activity in canine VSMCs.
- To investigate the role of cellular redox state and metabolic pathways in insulin-mediated cGMP production.
Main Methods:
- Primary canine VSMCs were cultured and treated with insulin.
- Measurements included lactate-to-pyruvate ratio (LPR) to assess redox state (NADH/NAD+), cGMP production, iNOS activity, and cell contraction.
- Specific inhibitors like NG-monomethyl-L-arginine (L-NMMA) and metabolic modulators (pyruvate, oxaloacetate) were used.
Main Results:
- Insulin significantly increased cGMP production and the LPR in VSMCs with iNOS, indicating a shift in the NADH/NAD+ redox state.
- Insulin's stimulation of cGMP was dependent on iNOS activity and the increased LPR, as blocking these pathways with L-NMMA or metabolic intermediates inhibited the effect.
- Insulin did not directly stimulate guanylate cyclase activity in cells lacking iNOS, suggesting an indirect mechanism involving iNOS-derived nitric oxide.
Conclusions:
- Insulin enhances cGMP production in VSMCs expressing iNOS by increasing the cellular NADH/NAD+ redox state.
- This metabolic alteration likely increases the availability of nitric oxide (NO) from iNOS, leading to cGMP production.
- The findings suggest an indirect mechanism where insulin modulates cellular metabolism to influence NO-cGMP signaling.
More Related Videos
08:22Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
Published on: March 20, 2017
07:56Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses
Published on: June 8, 2022
Related Concept Videos
Insulin Secretory Vesicles
GPCRs Regulate Adenylyl Cylase Activity
Two...
Nitric Oxide Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...